Drug company (FDA labeler)
Clinical Solutions Wholesale, LLC
NDC labeler code: 58118
What is a labeler?
The company whose name is on the package and in the FDA’s National Drug Code (NDC) Directory. It may make the medicine itself or sell medicine made by another company. The first part of every NDC code identifies the labeler.
Official FDA data only
Products, approvals and recalls come from the FDA (NDC Directory, Drugs@FDA, enforcement reports). Recalls are linked to this company by the NDC labeler code on the recalled product.
Questions about your medicine: ask your doctor or pharmacist. In an emergency, call 911.
Prescription medicines
- PregabalinLyrica, Lyrica CR · 14 products
- GabapentinNeurontin, Gralise, Relgaabi · 8 products
- BuprenorphineBelbuca, Brixadi, Buprenorphine Transdermal System · 6 products
- Buprenorphine and naloxoneZubsolv, Buprenorphine and Naloxone Sublingual Film, Suboxone · 5 products
- LorazepamAtivan, Loreev XR · 5 products
- ClonazepamKlonopin · 4 products
- AlprazolamXanax, Xanax XR · 4 products
- LacosamideVimpat, Motpoly XR · 4 products
- Clorazepate dipotassium3 products
- DiazepamValium, Valtoco · 3 products
- Chlordiazepoxide hydrochloride2 products
- Acetaminophen and codeine phosphate2 products
- Tramadol hydrochlorideConzip · 1 product
FDA applications for these products
- ANDA: Abbreviated New Drug Application: how a generic version is approved.
| Approved | Application | Medicine | Sponsor |
|---|---|---|---|
| March 29, 2023 | ANDA205321 | Pregabalin PREGABALIN | Aurobindo Pharma |
| March 17, 2022 | ANDA204787 | Lacosamide LACOSAMIDE | Hetero Labs Ltd V |
| October 1, 2021 | ANDA214957 | Gabapentin GABAPENTIN | Ascent Pharms Inc |
| July 17, 2020 | ANDA209069 | Buprenorphine and naloxone BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE | Wes Pharma Inc |
| July 19, 2019 | ANDA207799 | Pregabalin PREGABALIN | Alkem Labs Ltd |
| December 13, 2017 | ANDA207000 | Buprenorphine and naloxone BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE | Specgx LLC |
| March 27, 2017 | ANDA207276 | Buprenorphine BUPRENORPHINE HYDROCHLORIDE | Rhodes Pharms |
| January 29, 2016 | ANDA201760 | Buprenorphine BUPRENORPHINE HYDROCHLORIDE | Sun Pharm |
| July 31, 2015 | ANDA203346 | Alprazolam ALPRAZOLAM | Aurobindo Pharma |
| June 27, 2014 | ANDA203326 | Buprenorphine and naloxone BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE | Hikma |
| December 17, 2010 | ANDA090858 | Gabapentin GABAPENTIN | Alkem |
| October 8, 2009 | ANDA078633 | Buprenorphine BUPRENORPHINE HYDROCHLORIDE | Hikma |
| July 30, 2007 | ANDA078203 | Lorazepam LORAZEPAM | Leading |
| July 25, 2007 | ANDA078428 | Gabapentin GABAPENTIN | Amneal Pharms Ny |
| August 18, 2006 | ANDA077662 | Gabapentin GABAPENTIN | Glenmark Pharms Ltd |
| June 20, 2002 | ANDA076003 | Tramadol hydrochloride TRAMADOL HYDROCHLORIDE | Amneal Pharms |
| August 29, 2001 | ANDA076045 | Lorazepam LORAZEPAM | Sun Pharm Inds Ltd |
| May 31, 2001 | ANDA040419 | Acetaminophen and codeine phosphate ACETAMINOPHEN AND CODEINE PHOSPHATE | Specgx LLC |
| October 6, 2000 | ANDA075468 | Clonazepam CLONAZEPAM | Rubicon Research |
| April 27, 2000 | ANDA075731 | Clorazepate dipotassium CLORAZEPATE DIPOTASSIUM | Taro |
| September 10, 1996 | ANDA074569 | Clonazepam CLONAZEPAM | Teva |
| December 10, 1986 | ANDA071307 | Diazepam DIAZEPAM | Ivax Sub Teva Pharms |
| December 10, 1986 | ANDA071321 | Diazepam DIAZEPAM | Ivax Sub Teva Pharms |
| September 4, 1985 | ANDA070325 | Diazepam DIAZEPAM | Mylan |
| June 10, 1976 | ANDA083116 | Chlordiazepoxide hydrochloride CHLORDIAZEPOXIDE HYDROCHLORIDE | Barr |
| June 10, 1976 | ANDA084769 | Chlordiazepoxide hydrochloride CHLORDIAZEPOXIDE HYDROCHLORIDE | Barr |
The sponsor is the company that holds the FDA application; it can differ from the labeler.
Recall timeline
No recall of these products (by NDC code) appears in the FDA enforcement reports.
Sources
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026